Guo S, Zhang Q, Ge H, Wang H
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39661143
DOI: 10.1007/s00210-024-03704-5.
Yu C, Yang F, Zou Y, Zhang Y, Pan S
Medicine (Baltimore). 2024; 103(49):e40796.
PMID: 39654159
PMC: 11630941.
DOI: 10.1097/MD.0000000000040796.
Wan Q, Ren Q, Qiao S, Lyu A, He X, Li F
Front Nutr. 2024; 11:1477140.
PMID: 39650709
PMC: 11620852.
DOI: 10.3389/fnut.2024.1477140.
Zheng S, Qi W, Xue T, Zao X, Xie J, Zhang P
Heliyon. 2024; 10(20):e39176.
PMID: 39640799
PMC: 11620126.
DOI: 10.1016/j.heliyon.2024.e39176.
Yuan D, Xu W, Raza F, Zafar H, Guan S, Wang Z
Adv Pharmacol Pharm Sci. 2024; 2024:2869332.
PMID: 39624070
PMC: 11611450.
DOI: 10.1155/adpp/2869332.
Antibacterial effects of Kampo products against pneumonia causative bacteria.
Akahori Y, Hashimoto Y, Shizuno K, Nagasawa M
PLoS One. 2024; 19(10):e0312500.
PMID: 39466752
PMC: 11515972.
DOI: 10.1371/journal.pone.0312500.
Puerarin: a hepatoprotective drug from bench to bedside.
He Y, Liu M, Wu H, Lan Q, Liu H, Mazhar M
Chin Med. 2024; 19(1):139.
PMID: 39380120
PMC: 11460048.
DOI: 10.1186/s13020-024-01011-y.
Pharmacological mechanisms by which baicalin ameliorates cardiovascular disease.
Si L, Lai Y
Front Pharmacol. 2024; 15:1415971.
PMID: 39185317
PMC: 11341428.
DOI: 10.3389/fphar.2024.1415971.
Potential therapeutic effects of baicalin and baicalein.
Sabry K, Jamshidi Z, Emami S, Sahebka A
Avicenna J Phytomed. 2024; 14(1):23-49.
PMID: 38948180
PMC: 11210699.
DOI: 10.22038/AJP.2023.22307.
Molecular targets and therapeutic potential of baicalein: a review.
Munjal K, Goel Y, Gauttam V, Chopra H, Singla M, Smriti
Drug Target Insights. 2024; 18:30-46.
PMID: 38873988
PMC: 11168303.
DOI: 10.33393/dti.2024.2707.
The Therapeutic Effects of Baicalein on the Hepatopulmonary Syndrome in the Rat Model of Chronic Common Bile Duct Ligation.
Zeng Z, Lei Y, Yang C, Wu X, Zhang L, Yang Z
J Clin Transl Hepatol. 2024; 12(5):496-504.
PMID: 38779522
PMC: 11106353.
DOI: 10.14218/JCTH.2023.00513.
The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model.
Liu Z, Truong T, Bortolasci C, Spolding B, Panizzutti B, Swinton C
Mol Psychiatry. 2024; 29(8):2487-2495.
PMID: 38503930
PMC: 11412897.
DOI: 10.1038/s41380-024-02525-5.
Effect of et and on liver protection mechanism based on pharmacokinetics and metabonomics.
Feng G, Bi J, Jin W, Wang Q, Dan Z, Fan B
Chin Herb Med. 2024; 16(1):121-131.
PMID: 38375045
PMC: 10874764.
DOI: 10.1016/j.chmed.2023.10.002.
The Anti-Diabetic Potential of Baicalin: Evidence from Rodent Studies.
Szkudelski T, Szkudelska K
Int J Mol Sci. 2024; 25(1).
PMID: 38203600
PMC: 10779254.
DOI: 10.3390/ijms25010431.
Mechanism of the Effect of Compound . Oral Liquid in Treating Alcoholic Rat Liver Injury by Metabolomics.
Huang T, Wu Y, Huang L, Lin R, Li Z, Wang X
Drug Des Devel Ther. 2023; 17:3409-3428.
PMID: 38024538
PMC: 10659148.
DOI: 10.2147/DDDT.S427837.
Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers.
Yang W, Wang W, Cai S, Li P, Zhang D, Ning J
Molecules. 2023; 28(21).
PMID: 37959836
PMC: 10650756.
DOI: 10.3390/molecules28217417.
Topical Application of Baicalin Combined with Echinacoside Ameliorates Psoriatic Skin Lesions by Suppressing the Inflammation-Related TNF Signaling Pathway and the Angiogenesis-Related VEGF Signaling Pathway.
Chen Y, Wang Y, Song S, Zhang X, Wu L, Wu J
ACS Omega. 2023; 8(43):40260-40276.
PMID: 37929119
PMC: 10620902.
DOI: 10.1021/acsomega.3c04281.
Flavonoids improve type 2 diabetes mellitus and its complications: a review.
Yi X, Dong M, Guo N, Tian J, Lei P, Wang S
Front Nutr. 2023; 10:1192131.
PMID: 37324738
PMC: 10265523.
DOI: 10.3389/fnut.2023.1192131.
Baicalin-Current Trends in Detection Methods and Health-Promoting Properties.
Bajek-Bil A, Chmiel M, Wloch A, Stompor-Goracy M
Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111327
PMC: 10146343.
DOI: 10.3390/ph16040570.
Baicalin attenuates dexamethasone-induced apoptosis of bone marrow mesenchymal stem cells by activating the hedgehog signaling pathway.
Jia B, Jiang Y, Yao Y, Xu Y, Wang Y, Li T
Chin Med J (Engl). 2023; 136(15):1839-1847.
PMID: 36804262
PMC: 10406080.
DOI: 10.1097/CM9.0000000000002113.